Should You Buy Applied Therapeutics Inc (APLT) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast APLT stock price to rise
4 Analyst Rating
Wall Street analysts forecast APLT stock price to rise
0 Buy
4 Hold
0 Sell
Hold
Current: 0.103
Low
0.25
Averages
0.25
High
0.25
Current: 0.103
Low
0.25
Averages
0.25
High
0.25
Leerink
Outperform -> Market Perform
downgrade
$2 -> $1
AI Analysis
2025-12-03
Reason
Leerink
Price Target
$2 -> $1
AI Analysis
2025-12-03
downgrade
Outperform -> Market Perform
Reason
Leerink downgraded Applied Therapeutics to Market Perform from Outperform with a price target of $1, down from $2. With growing concerns over Applied Therapeutics' balance sheet and the likelihood that the company will need to run two additional Phase 3 studies to get govorestat across the goal line, the firm is moving to the sidelines and cutting the stock's rating to Marker Perform.
Leerink
Joseph Schwartz
Outperform
to
Market Perform
downgrade
$1
2025-12-03
Reason
Leerink
Joseph Schwartz
Price Target
$1
2025-12-03
downgrade
Outperform
to
Market Perform
Reason
Leerink analyst Joseph Schwartz downgraded Applied Therapeutics to Market Perform from Outperform with a $1 price target.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for APLT
